Analyst Price Target is $50.55
▼ -5.29% Downside Potential
This price target is based on 8 analysts offering 12 month price targets for Aflac in the last 3 months. The average price target is $50.55, with a high forecast of $61.00 and a low forecast of $37.00. The average price target represents a -5.29% upside from the last price of $53.37.
Current Consensus is
The current consensus among 8 polled investment analysts is to hold stock in Aflac. This Hold consensus rating has held steady for over two years.
Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. It operates through two segments, Aflac Japan and Aflac U.S. The Aflac Japan segment offers cancer, medical, income support, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan. The Aflac U.S. segment provides cancer, accident, short-term disability, critical care, hospital indemnity, dental, vision, long-term care and disability, and term and whole life insurance products in the United States. It sells its products through sales associates, brokers, independent corporate agencies, individual agencies, and affiliated corporate agencies. The company was founded in 1955 and is headquartered in Columbus, Georgia.